AUTHOR=Atkins Whitley C. , McDermott Brendon P. , Colburn Abigail T. , Kavouras Stavros A. 

TITLE=Response to a Water Bolus in Long Term Oral Contraceptive Users

JOURNAL=Frontiers in Sports and Active Living

VOLUME=4

YEAR=2022

URL=https://www.frontiersin.org/journals/sports-and-active-living/articles/10.3389/fspor.2022.857719

DOI=10.3389/fspor.2022.857719

ISSN=2624-9367

ABSTRACT=<p>The purpose of our study was to determine the responses to an acute water bolus in long-term oral contraception (OCP) users. Seventeen female volunteers (27 ± 5 y, 64.1 ± 13.7 kg, 39.6 ± 5.9 kg/LBM) provided consent and enrolled in our study. All were long-term OCP users and participated in two trials, one during the active pill (High Hormone, HH) dose of their prescribed OCP and one during the sham pill (Low Hormone, LH) dose. Participants reported to the laboratory euhydrated, were fed breakfast, remained seated for 60 min and were provided a bolus of room temperature water in the amount of 12 mL/kg/LBM. Urine output over 180 min was measured. Nude body mass was measured pre- and post-trial. Urine specific gravity (USG) and urine osmolality were analyzed. Between trials, there were no differences in 3-h total urine volume (<italic>P</italic> = 0.296), 3-h USG (<italic>P</italic> = 0.225), 3-h urine osmolality (<italic>P</italic> = 0.088), or 3-h urine frequency (<italic>P</italic> = 0.367). Heart rate was not different between trials (<italic>P</italic> = 0.792) nor over time (<italic>P</italic> = 0.731). Mean arterial pressure was not different between trials (<italic>P</italic> = 0.099) nor over time (<italic>P</italic> = 0.262). Perceived thirst demonstrated a significant main effect for increasing over time regardless of trial (<italic>P</italic> &lt; 0.001) but there was no difference between trials (<italic>P</italic> = 0.731). The urgency to void was not different between trials (<italic>P</italic> = 0.149) nor over time (<italic>P</italic> = 0.615). Plasma volume change was not different between trials (<italic>P</italic> = 0.847) (HH: −3.4 ± 5.0, LH post: −3.8 ± 4.5%) and plasma osmolality did not differ between trials (<italic>P</italic> = 0.290) nor over time (<italic>P</italic> = 0.967) (HH pre: 290 ± 4, HH post: 289 ± 4, LH pre: 291 ± 4, LH post: 291 ± 4 m<sub>osm</sub>/L). Blood glucose significantly decreased over time (<italic>P</italic> &lt; 0.001) but there was no difference between trials (<italic>P</italic> = 0.780) (HH pre: 95.9 ± 113.9, HH post: 86.8 ± 6.5, LH pre: 95.9 ± 13.5, LH post: 84.6 ± 9.4 mmol/L). Copeptin concentration did not differ between phases of OCP use (<italic>P</italic> = 0.645) nor from pre- to post-trial (<italic>P</italic> = 0.787) Despite fluctuations in hormone concentrations, responses to a water bolus seem to be unaffected in OCP users in euhydrated, resting conditions.</p>